Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan J Ruby

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Retina (Philadelphia, Pa.)|June 17, 2017
DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF RECALCITRANT MACULAR EDEMA AFTER RHEGMATOGENOUS RETINAL DETACHMENT REPAIRAristomenis Thanos, Bozho Todorich, Yoshihiro Yonekawa, et al.
Retina (Philadelphia, Pa.)|September 1, 2021
LONG-TERM VISUAL OUTCOMES AND THE TIMING OF SURGICAL REPAIR OF FOVEA-SPLITTING RHEGMATOGENOUS RETINAL DETACHMENTSRamon Lee, Ryan A Shields, Michael J Maywood, et al.
Retina (Philadelphia, Pa.)|September 24, 2020
PERIPHERAL RETINAL ANGIOGRAPHIC FINDINGS IN MACULAR TELANGIECTASIS TYPE 2Stavros N Moysidis, Nicole Koulisis, Prethy Rao, et al.
Retina (Philadelphia, Pa.)|October 30, 2023
LONG-TERM USE OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONTedi Begaj, Daeun Jeong, Jong G Park, et al.
Ophthalmology. Retina|April 2, 2019
Predictors of Endophthalmitis after Intravitreal Injection: A Multivariable Analysis Based on Injection Protocol and Povidone Iodine StrengthMaxwell S Stem, Prethy Rao, Ivan J Lee, et al.
JAMA Ophthalmology|May 7, 2013
Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4, Emily Y Chew, John Paul SanGiovanni, et al.
JAMA Ophthalmology|December 7, 2013
Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3, Emily Y Chew, Traci E Clemons, et al.
Ophthalmology. Retina|May 21, 2019
Characterization of Epiretinal Proliferation in Full-Thickness Macular Holes and Effects on Surgical OutcomesEsther Lee Kim, Adam J Weiner, Cindy Ung, et al.
Retina (Philadelphia, Pa.)|October 20, 2020
CLINICAL OUTCOMES AND TREATMENT COURSE OF EYES WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION FOLLOWING THE DEVELOPMENT OF ENDOPHTHALMITISNicole Koulisis, Stavros N Moysidis, Viren K Govindaraju, et al.
Ophthalmology|September 3, 2023
Surgical Management of Full-Thickness Macular Holes in Macular Telangiectasia Type 2: A Global Multicenter StudyJong G Park, Sean D Adrean, Tedi Begaj, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Retina (Philadelphia, Pa.)|June 17, 2017
DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF RECALCITRANT MACULAR EDEMA AFTER RHEGMATOGENOUS RETINAL DETACHMENT REPAIRAristomenis Thanos, Bozho Todorich, Yoshihiro Yonekawa, et al.
Retina (Philadelphia, Pa.)|September 1, 2021
LONG-TERM VISUAL OUTCOMES AND THE TIMING OF SURGICAL REPAIR OF FOVEA-SPLITTING RHEGMATOGENOUS RETINAL DETACHMENTSRamon Lee, Ryan A Shields, Michael J Maywood, et al.
Retina (Philadelphia, Pa.)|September 24, 2020
PERIPHERAL RETINAL ANGIOGRAPHIC FINDINGS IN MACULAR TELANGIECTASIS TYPE 2Stavros N Moysidis, Nicole Koulisis, Prethy Rao, et al.
Retina (Philadelphia, Pa.)|October 30, 2023
LONG-TERM USE OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONTedi Begaj, Daeun Jeong, Jong G Park, et al.
Ophthalmology. Retina|April 2, 2019
Predictors of Endophthalmitis after Intravitreal Injection: A Multivariable Analysis Based on Injection Protocol and Povidone Iodine StrengthMaxwell S Stem, Prethy Rao, Ivan J Lee, et al.
JAMA Ophthalmology|May 7, 2013
Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4, Emily Y Chew, John Paul SanGiovanni, et al.
JAMA Ophthalmology|December 7, 2013
Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3, Emily Y Chew, Traci E Clemons, et al.
Ophthalmology. Retina|May 21, 2019
Characterization of Epiretinal Proliferation in Full-Thickness Macular Holes and Effects on Surgical OutcomesEsther Lee Kim, Adam J Weiner, Cindy Ung, et al.
Retina (Philadelphia, Pa.)|October 20, 2020
CLINICAL OUTCOMES AND TREATMENT COURSE OF EYES WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION FOLLOWING THE DEVELOPMENT OF ENDOPHTHALMITISNicole Koulisis, Stavros N Moysidis, Viren K Govindaraju, et al.
Ophthalmology|September 3, 2023
Surgical Management of Full-Thickness Macular Holes in Macular Telangiectasia Type 2: A Global Multicenter StudyJong G Park, Sean D Adrean, Tedi Begaj, et al.
Pageof 3